In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
If Joe Biden is elected this November, Kamala Harris would be the first woman and the first person of color to serve as vice president. We asked Prof. Oriane Georgeac, who studies perceptions of diversity, if Harris’s nomination heralds an acceleration of progress for women generally.
Some have defended cutbacks to the United States Postal Service, weeks ahead of the election, by citing the USPS’s financial struggles. But the postal service was created to provide a public service, writes Yale SOM’s Jeffrey Sonnenfeld, not to turn a profit.
The Trump administration is reportedly planning to limit immigration for skilled workers in order to boost employment for domestic workers. Yale SOM’s Jeffrey Sonnenfeld writes that such a move would stifle innovation and even endanger Americans’ health.
On March 12, a group of public health experts assembled by Yale SOM’s Dr. Howard Forman released a proposal for a set of emergency public health, healthcare, and emergency support measures to respond to the growing COVID-19 outbreak.
Leadership experts Jeffrey Sonnenfeld of Yale SOM and General Thomas Kolditz of Rice University write that Trump’s interference in the Gallagher case violates a key principle of military law and undermines the military command structure.
A panel of experts from the Global Network for Advanced Management discussed the prolonged, contentious Brexit process and what the future likely holds for businesses and citizens with ties to Britain.